Personalized Medicine Expert Gains Prominent FDA Role In Agency Reorg
This article was originally published in The Gray Sheet
Executive Summary
Commissioner Margaret Hamburg’s reorganization at the top of FDA puts an expert in pediatric drug development and pharmacogenomics in a new post overseeing four of the seven agency centers, including the device unit.